StockTipsArenaBeta

BUY Gland Pharma Limited — Raja Venkatraman

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byRaja VenkatramanHorizon: 1–3 months25 Jun 2026via LiveMint Markets

Entry₹2,330Stated
Target₹2,675
Total upside +14.81% (call closed)
Stop loss₹2,180-6.44% risk
Exit₹2,67510 Aug 2026, 12:08 pm
Target hit+14.81%0.00%upside left
Follow Raja Venkatraman for new calls(23% target hit, 56 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 4 active Short-term calls on GLANDSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 10 Aug 2026
5 supporting1 opposing
Supports the BUY call (5)

Gland Pharma has entered into a strategic Contract Development and Manufacturing Organization (CDMO) partnership with an unnamed global pharmaceutical company. This collaboration is expected to enhanc

BSE · Company Update·9 Aug · yesterday

(opens in new tab)

Gland Pharma Ltd has entered into a strategic collaboration with Neuland Laboratories for the manufacturing of sterile Active Pharmaceutical Ingredients (APIs).

BSE · Company Update·5 Aug · 4d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·30 Jul · 2w ago

Gland Pharma Ltd has received approval for its Suggamadex Injection.

BSE · Company Update·29 Jul · 2w ago

(opens in new tab)

3 other SEBI-registered advisors have active short-term BUY calls on this stock

Advisor consensus · same horizon·24 Jul · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Raja Venkatraman

Every call and its outcome